MarketScreener Editorial Features Lonza Group AG
Stocks
LONN
CH0013841017
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 567.80 CHF | -1.29% |
|
-3.11% | +5.58% |
| 15/07 | Lonza Reaffirmed at Outperform as RBC Notes Tight Supply, Demand in Biologics | MT |
| 14/07 | Swiss Market Index Slips; Roche Shares Down | MT |
MarketScreener Editorial Features
Search
 | European sovereignty, defense… Oddo BHF presents its "Magnificent Seven" | October 07, 2025 at 12:48 pm IST |
 | On the stockmarket, the pharmaceutical industry is wary of FDA's new strongman | May 07, 2025 at 04:00 pm IST |
 | Indices: Five Magnificents instead of Seven | April 02, 2024 at 09:08 pm IST |
 | Indices: Wishing you a Happy New Year and, above all, good health! | January 08, 2024 at 10:25 pm IST |
 | MarketScreener's World Press Review : January 26, 2022 | January 26, 2022 at 07:46 pm IST |
 | Today's analyst recommendations: Alibaba, BioNTech, Home Depot, Lowe's, Roblox... | May 13, 2021 at 04:04 pm IST |
No results match your criteria
- Stock Market
- Stocks
- LONN Stock
- News Lonza Group AG
- MarketScreener Editorial Features
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition